Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ALK-positive Advanced NSCLC × Thoracic × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1678 Lung Neoplasms 1147 Small Cell Lung Carcinoma 276 Colorectal Neoplasms 242 Breast Neoplasms 217 Neoplasms 203 Melanoma 197 Ovarian Neoplasms 169 Neoplasm Metastasis 157 Pancreatic Neoplasms 142 Squamous Cell Carcinoma of Head and Neck 138 Stomach Neoplasms 126 Carcinoma, Renal Cell 106 Head and Neck Neoplasms 103 Triple Negative Breast Neoplasms 98 Prostatic Neoplasms 98 Esophageal Neoplasms 94 Urinary Bladder Neoplasms 88 Endometrial Neoplasms 88 Uterine Cervical Neoplasms 84 Mesothelioma, Malignant 81 Colonic Neoplasms 80 Mesothelioma 79 Brain Neoplasms 66 Carcinoma, Hepatocellular 62 Sarcoma 59 Adenocarcinoma of Lung 48 NSCLC 47 Carcinoma 47 Disease 45

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03535740 2025-07-31

ALTA-2

Takeda

Phase 2 Completed

103 enrolled 23 charts

ALK-positive Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡